慢性肾脏病孕妇发生严重孕产妇并发症和死亡的风险
基于美国2010-2020年住院分娩数据的回顾性队列研究,共纳入38,374,326例产妇,其中95,272例(0.2%)患有慢性肾脏病。慢性肾脏病组严重孕产妇并发症风险为12.2%,显著高于无慢性肾脏病组的0.7%(aRR 6.4,95%CI 6.0-6.8),孕产妇死亡风险亦升高(aRR 4.1,95%CI 2.9-5.8)。
要点
- 慢性肾脏病孕妇严重孕产妇并发症风险显著升高(12.2% vs 0.7%,aRR 6.4)。
- 急性肾衰竭(aRR 21.7)和脓毒症(aRR 9.0)风险最高。
- 肾移植史与慢性肾脏病1期患者严重并发症和死亡风险相似。
核心结论
- 妊娠合并慢性肾脏病与严重孕产妇并发症、死亡及其他不良围产结局显著相关,需在整个孕期密切监测和多学科管理。
研究设计与样本
- 基于美国医疗成本与利用项目全国住院患者样本数据库的回顾性队列研究,纳入2010-2020年美国住院分娩病例。
- 共纳入38,374,326例产妇,其中95,272例(0.2%)患有慢性肾脏病。
- 采用国际疾病分类第9版和第10版编码识别分娩住院、慢性肾脏病和严重孕产妇并发症。
- 主要结局为根据美国疾病控制与预防中心标准定义的严重孕产妇并发症和死亡。
- 采用多变量logistic回归分析估计校正相对危险度和95%置信区间。
主要发现
- 慢性肾脏病组严重孕产妇并发症风险为12.2%,无慢性肾脏病组为0.7%(aRR 6.4,95%CI 6.0-6.8)。
- 严重孕产妇并发症指标中,慢性肾脏病组急性肾衰竭风险最高(aRR 21.7,95%CI 19.8-23.7),其次为脓毒症(aRR 9.0,95%CI 7.6-10.5)。
- 慢性肾脏病与孕产妇死亡风险升高相关(aRR 4.1,95%CI 2.9-5.8)。
- 黑人个体中严重孕产妇并发症与慢性肾脏病的校正人群归因分数较高(aPAF 4.0%,95%CI 3.6-4.3)。
- 所有慢性肾脏病亚型、分期及肾移植史均与严重孕产妇并发症风险升高相关;孕产妇死亡与糖尿病肾病、肾血管疾病、梗阻性或未特指肾脏疾病(aRR 7.3-14.1)以及慢性肾脏病3-5期和肾移植史(aRR 15.5-32.6)显著相关。
临床怎么用
- 原文结论指出妊娠合并慢性肾脏病需在整个孕期密切监测和多学科管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic kidney disease is a significant cause of adverse obstetric outcomes. However, there are few studies assessing the risk of severe maternal morbidity and mortality among patients with chronic kidney disease and no studies assessing the association between individual indicators of severe maternal morbidity and chronic kidney disease. OBJECTIVE: To evaluate the risk of severe maternal morbidity and mortality among pregnant patients with chronic kidney disease. STUDY DESIGN: This was a population-based, retrospective cohort study including U.S. delivery hospitalizations from 2010-2020 utilizing the Healthcare Cost & Utilization Project National Inpatient Sample database. Patients were identified as having a delivery hospitalization, chronic kidney disease, and severe maternal morbidity using International Classification Diagnoses codes (9th and 10th edition). The primary outcomes were severe maternal morbidity and mortality, as defined according to the Centers for Disease Control and Prevention criteria. Multivariate logistic regression analyses were performed to estimate adjusted relative risk and 95% confidence intervals of severe maternal morbidity and mortality among patients with chronic kidney disease. Subgroup analyses were performed by chronic kidney disease etiology, stage, race and ethnicity, and individual indicators of severe maternal morbidity. RESULTS: Among the 38,374,326 parturients in this study, 95,272 (0.2%) had chronic kidney disease. The risk of severe maternal morbidity was higher for those with chronic kidney disease (12.2% vs 0.7%, aRR 6.4, 95% CI 6.0-6.8) compared to those without. Among severe maternal morbidity indicators, those with chronic kidney disease were at highest risk for acute renal failure (aRR 21.7, 95% CI 19.8-23.7) and sepsis (aRR 9.0, 95% CI 7.6-10.5). Chronic kidney disease was also associated with an increased risk of maternal death (aRR 4.1, 95% CI 2.9-5.8). Black individuals had higher adjusted population attributable fraction (aPAF) between severe maternal morbidity and chronic kidney disease (aPAF 4.0%, 95% CI 3.6-4.3). Increased risk of severe maternal morbidity was associated with all chronic kidney disease subtypes, stages, and a history of renal transplant. Maternal death was significantly associated with diabetic nephropathy, renovascular, and obstructive or unspecified renal disease (aRR 7.3-14.1), as well as stages 3-5 of chronic kidney disease and a history of renal transplant (aRR 15.5-32.6). Risk of severe maternal morbidity and mortality were similar in those with a history of renal transplant and those with stage 1 chronic kidney disease. The number needed to treat with renal transplant to prevent 1 severe maternal morbidity event or maternal death in those with stages 3-5 chronic kidney disease was 2.6 (95% CI 2.4-2.9) and 45.0 (95% CI 31.0-82.0), respectively. CONCLUSION: Chronic kidney disease in pregnancy was significantly associated with severe maternal morbidity, mortality, and other adverse perinatal outcomes, warranting close surveillance and multidisciplinary management throughout pregnancy.
引用
- Xu JH, Czarny HN, Toledo I, et al. Risk of severe maternal morbidity and mortality among pregnant patients with chronic kidney disease. Am J Obstet Gynecol MFM. 2025. PMID: 39755249. doi:10.1016/j.ajogmf.2024.101594
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。